Filing Details
- Accession Number:
- 0001209191-20-002501
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-01-08 16:11:46
- Reporting Period:
- 2020-01-06
- Accepted Time:
- 2020-01-08 16:11:46
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1661567 | Michael Parini | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Evp, Cl&Ao | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-01-06 | 4,250 | $122.45 | 39,253 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-01-06 | 400 | $218.93 | 38,853 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-01-06 | 461 | $220.69 | 38,392 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-01-06 | 1,599 | $221.49 | 36,793 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-01-06 | 398 | $222.67 | 36,395 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-01-06 | 1,063 | $223.60 | 35,332 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-01-06 | 329 | $224.11 | 35,003 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-01-06 | 4,250 | $0.00 | 4,250 | $122.45 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2026-01-03 | No | 4 | M | Direct |
Footnotes
- Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $218.93 (range $218.40 to $219.37).
- Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $220.69 (range $220.32 to $220.99).
- Open market sales reported on this line occurred at a weighted average price of $221.49 (range $221.00 to $221.82).
- Open market sales reported on this line occurred at a weighted average price of $222.67 (range $222.14 to $222.99).
- Open market sales reported on this line occurred at a weighted average price of $223.60 (range $223.19 to $223.99).
- Open market sales reported on this line occurred at a weighted average price of $224.11 (range $224.02 to $224.27).
- Fully vested.
Billionaire Hedge Funds
